Literature DB >> 25663268

Gender-specific effects on food intake but no inhibition of age-related fat accretion in transgenic mice overexpressing human IGFBP-2 lacking the Cardin-Weintraub sequence motif.

Petra Wiedmer1, Franziska Schwarz, Birgit Große, Nancy Schindler, Armin Tuchscherer, Vincenzo C Russo, Matthias H Tschöp, Andreas Hoeflich.   

Abstract

IGFBP-2 affects growth and metabolism and is thought to impact on energy homeostasis and the accretion of body fat via its heparin binding domains (HBD). In order to assess the function of the HBD present in the linker domain (HBD1) we have generated transgenic mice overexpressing mutant human IGFBP-2 lacking the PKKLRP sequence and carrying a PNNLAP sequence instead. Transgenic mice expressed high amounts of human IGFBP-2, while endogenous IGFBP-2 or IGF-I serum concentrations were not affected. In both genders we performed a longitudinal analysis of growth and metabolism including at least 4 separate time points between the age of 10 and 52 weeks. Body composition was assessed by nuclear magnetic resonance (NMR) analysis. Food intake was recorded by an automated online-monitoring. We describe negative effects of mutant human IGFBP-2 on body weight, longitudinal growth and lean body mass (p < 0.05). Very clearly, negative effects of mutant IGFBP-2 were not observed for fat mass accretion throughout life. Instead, relative fat mass was increased in transgenic mice of both genders (p < 0.05). In male mice transgene expression significantly increased absolute mass of total body fat over all age groups (p < 0.05). Food intake was increased in female but decreased in male transgenic mice at an age of 11 weeks. Thus our study clearly provides gender- and time-specific effects of HBD1-deficient hIGFBP-2 (H1d-BP-2) on fat mass accretion and food intake. While our data are in principal agreement with current knowledge on the role of HB-domains for fat accretion we now may also speculate on a role of HBD1 for the control of eating behavior.

Entities:  

Year:  2015        PMID: 25663268      PMCID: PMC4458247          DOI: 10.1007/s12079-015-0264-z

Source DB:  PubMed          Journal:  J Cell Commun Signal        ISSN: 1873-9601            Impact factor:   5.782


  27 in total

1.  Increased fat mass, decreased myofiber size, and a shift to glycolytic muscle metabolism in adolescent male transgenic mice overexpressing IGFBP-2.

Authors:  Charlotte Rehfeldt; Ulla Renne; Mandy Sawitzky; Gerhard Binder; Andreas Hoeflich
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-05-25       Impact factor: 4.310

2.  Insulin-like growth factor binding protein-2 binds to cell surface proteoglycans in the rat brain olfactory bulb.

Authors:  V C Russo; L A Bach; A J Fosang; N L Baker; G A Werther
Journal:  Endocrinology       Date:  1997-11       Impact factor: 4.736

3.  Sexually dimorphic role of G protein-coupled estrogen receptor (GPER) in modulating energy homeostasis.

Authors:  Kathryn E Davis; Elizabeth J Carstens; Boman G Irani; Lana M Gent; Lisa M Hahner; Deborah J Clegg
Journal:  Horm Behav       Date:  2014-02-18       Impact factor: 3.587

4.  Overexpression of insulin-like growth factor-binding protein-2 in transgenic mice reduces postnatal body weight gain.

Authors:  A Hoeflich; M Wu; S Mohan; J Föll; R Wanke; T Froehlich; G J Arnold; H Lahm; H J Kolb; E Wolf
Journal:  Endocrinology       Date:  1999-12       Impact factor: 4.736

5.  Binding of insulin-like growth factor (IGF) I or II to IGF-binding protein-2 enables it to bind to heparin and extracellular matrix.

Authors:  T Arai; W Busby; D R Clemmons
Journal:  Endocrinology       Date:  1996-11       Impact factor: 4.736

6.  Antidiabetic effects of IGFBP2, a leptin-regulated gene.

Authors:  Kristina Hedbacker; Kivanç Birsoy; Robert W Wysocki; Esra Asilmaz; Rexford S Ahima; I Sadaf Farooqi; Jeffrey M Friedman
Journal:  Cell Metab       Date:  2010-01       Impact factor: 27.287

7.  Gender-specific changes in bone turnover and skeletal architecture in igfbp-2-null mice.

Authors:  V E DeMambro; D R Clemmons; L G Horton; M L Bouxsein; T L Wood; W G Beamer; E Canalis; C J Rosen
Journal:  Endocrinology       Date:  2008-02-14       Impact factor: 4.736

8.  Insulin-like growth factor (IGF) binding protein 2 functions coordinately with receptor protein tyrosine phosphatase β and the IGF-I receptor to regulate IGF-I-stimulated signaling.

Authors:  Xinchun Shen; Gang Xi; Laura A Maile; Christine Wai; Clifford J Rosen; David R Clemmons
Journal:  Mol Cell Biol       Date:  2012-08-06       Impact factor: 4.272

9.  Insulin-like growth factor binding protein 2 (IGFBP-2) promotes growth and survival of breast epithelial cells: novel regulation of the estrogen receptor.

Authors:  Emily J Foulstone; Li Zeng; Claire M Perks; Jeff M P Holly
Journal:  Endocrinology       Date:  2013-03-20       Impact factor: 4.736

10.  Cinnamon extract improves insulin sensitivity in the brain and lowers liver fat in mouse models of obesity.

Authors:  Tina Sartorius; Andreas Peter; Nadja Schulz; Andrea Drescher; Ina Bergheim; Jürgen Machann; Fritz Schick; Dorothea Siegel-Axel; Annette Schürmann; Cora Weigert; Hans-Ulrich Häring; Anita M Hennige
Journal:  PLoS One       Date:  2014-03-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.